CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $371,000 | +62.0% | 7,665 | +31.7% | 0.14% | +26.3% |
| Q2 2022 | $229,000 | -31.8% | 5,820 | -65.7% | 0.11% | -62.7% |
| Q2 2021 | $336,000 | +27.8% | 16,978 | -46.3% | 0.31% | +268.7% |
| Q2 2018 | $263,000 | +224.7% | 31,627 | +181.8% | 0.08% | +315.0% |
| Q1 2018 | $81,000 | -55.2% | 11,222 | -49.4% | 0.02% | -62.3% |
| Q4 2017 | $181,000 | -58.5% | 22,175 | -38.4% | 0.05% | -64.9% |
| Q2 2017 | $436,000 | +142.2% | 36,000 | +109.3% | 0.15% | +8.6% |
| Q4 2015 | $180,000 | – | 17,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |